Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION - Sonoma Pharmaceuticals, Inc. | sonoma_ex-3102.htm |
| EX-31.1 - CERTIFICATION - Sonoma Pharmaceuticals, Inc. | sonoma_ex-3101.htm |
| EX-23.1 - INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT - Sonoma Pharmaceuticals, Inc. | sonoma_ex-2301.htm |
| EX-21.1 - SUBSIDIARIES OF REGISTRANT - Sonoma Pharmaceuticals, Inc. | sonoma_ex-2101.htm |
| EX-10.36 - AMENDMENT NO. 8 TO LEASE - Sonoma Pharmaceuticals, Inc. | sonoma_ex1034.htm |
| EX-10.33 - DISTRIBUTION AGREEMENT - Sonoma Pharmaceuticals, Inc. | sonoma_ex1033.htm |
| EX-10.32 - MASTER VENDOR AGREEMENT - Sonoma Pharmaceuticals, Inc. | sonoma_ex1032.htm |
| EX-4.1 - SPECIMEN STOCK CERTIFICATE - Sonoma Pharmaceuticals, Inc. | sonoma_ex0401.htm |
| 10-K - FORM 10-K - Sonoma Pharmaceuticals, Inc. | sonoma_10k-033117.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officers of Sonoma Pharmaceuticals, Inc., a Delaware corporation (the “Company”), do hereby certify, to such officers’ knowledge, that:
The Annual Report on Form 10-K for the year ended March 31, 2017 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: June 28, 2017 | By: | /s/ Jim Schutz | |
|
Jim Schutz Chief Executive Officer (Principal Executive Officer) |
|||
| Date: June 28, 2017 | By: | /s/ Robert Miller | |
|
Robert Miller Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |